Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea

Inclusion Criteria: * Diagnosis of papulopustular rosacea * Free of any clinically significant disease, which could interfere with the study * Male or female subject aged ≥ 18 years * Willingness of subject to follow all study procedures * Signed written informed consent before any study-related activities are carried out Exclusion Criteria: * Subjects who are known to be non-responders to azelaic acid * Presence of dermatoses that might interfere with rosacea diagnosis * Ocular rosacea; phymatous rosacea; subjects with plaque-type rosacea lesions, papulopustular rosacea that requires systemic treatment * Topical use of any prescription or non-prescription medication to treat rosacea within 6 weeks prior to randomization and throughout the study * Systemic use of any prescription or non-prescription medication to treat rosacea (Retinoids within 6 months, Tetracycline within 2 months, Corticosteroids, erythromycin, azithromycin, and/or metronidazole within 4 weeks) prior to randomization and throughout the study * Facial laser surgery for telangiectasia (or other conditions) within 6 weeks prior to randomization * Known hypersensitivity to any ingredients of the investigational product formulation * Participation in another clinical research in parallel or within the last 4 weeks before randomization in this study * Any condition or therapy that in the investigator's opinion may pose a risk to the subject or that could interfere with any evaluation in the study